Dial-in Number
| Web session
|
HL7 Antitrust Policy
Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).
Attendees
Name | Organization | Attendance |
---|---|---|
Scott Robertson (Chair) | Kaiser | x |
John Hatem (Scribe) | Independent Consultant | x |
Isaac Vetter | Epic | |
Christof Gessner | HL7 Germany | x |
Shelly Spiro | Pharmacy HIT Collaborative | x |
Brad Wise | Humana | |
Stephen Chu | ADHA | |
Danielle Bancroft | x | |
Corey Spears | MITRE | x |
Frank McKinney | POCP | |
Dave Hill | MITRE | x |
Peter Sergent | HL7 New Zealand | x |
Joe Quinn | ||
Tim McNeil | Surescript | x |
Reed D. Gelzer | Trustworthy EHR | x |
Margaret Weiker | NCPDP | x |
Agenda Items and Notes
Meeting Notes from previous meeting
Project Review
Project Proposals
- Project Proposals in Review - none to review
Project Scope Statements
- Project Scope Statements
- [PSS-1884] Consultant Pharmacist Consult Note update
- Reviewed: Motion to approve: Jean Duteau / John Hatem. Motion passed: 10-0-0
- [PSS-1884] Consultant Pharmacist Consult Note update
Discussion of MedicationKnowledge changes (Jean Duteau)
- - no discussion
Catalog Updates (John Hatem)
- - Catalog minutes from Dec 3 meeting: 2021-12-03 Catalog - Orders & Observations
- no Pharmacy specific issues; still targeting next Catalog release for May 2022
Workflow Update (John Hatem)
- - unable to attend Workflow meeting on Dec 6th. Plan was to discuss Contract issues
Healthcare Product Update (John Hatem)
- discussed device Jira's - no pharmacy impact
- Open question is whether Pharmacy should reference Biological Derived Product resource in our Pharmacy resources, e.g. MedicationRequest, MedicationDispense, MedicationAdministration
NCPDP Updates (NCPDP Members)
-
- NCPDP Task Group working on Patient Consent - for specialty prescribing
- Meeting scheduled for December 9th
- RealTime Pharmacy Benefit Check for Consumers
- Meeting scheduled for December 13th
- Consultant Pharmacist Task Force
- Reviewed HL7 PSS
- Begin review of the 20211202 Consultant Pharmacist Consult Note document
- Specialty Enrolment PSS (Frank/Maggie)
- Meeting scheduled for December 7th
- NCPDP Task Group working on Patient Consent - for specialty prescribing
Meeting information can be obtained at https://dms.ncpdp.org/
Global Supply Chain Project (Scott)
Medication List Guidance project (John)
- - no updates this week
- Reviewed at a high level the current work
Projects
Pharmacy Templates
- - items below are carried over from last week
- waiting for requirements from Christof and then will decide on next steps for new version
- Still waiting for approval of change request in Europe
- additional elements to be added - part relationship
PDex Formulary (Corey)
- - items below are carried over from last week
- Bulk Data change - not specifically included in the scope of the PSS - but PSS is not specific to formulary
- Need to look at the scope of the PSS to be clear about what the PSS is about
- Bulk Data change - not specifically included in the scope of the PSS - but PSS is not specific to formulary
Medication List Project from EHR
-
- Scott R provide some background and context for the discussion and introduced Reed Gelzer
- Reed provided a summary overview of the current work and answered several questions. Focus is US Realm. Reed did share he expects the work to be taken up by a new facilitator and that the work is expected to start sometime in Feb 2022.
- Project Candidate 09 10 2021 NCPDP.pdf slides used during meeting by Reed
- There is not a PSS for the past work and as such no formal HL7 deliverables. I characterize the past work as a requirements and information gathering with a focus driven by CMS Reducing Clinician Burden. Out of a clinical focus group discussion, it was decided to outline a Medication Reconciliation workproduct.
- There is a plan for producing a FHIR IG (v4) and some additional work being discussed regarding APIs. This is very new work, and no PSS exists yet for this work. Focus appears to be US Realm
- John H promised to reach out to Reed and share what we have been doing within Pharmacy regarding Medication Lists.
Nutrition
- carried over from last week's meeting
International Patient Access
- - John attend Wed meeting on Dec 1st. No issues to report, they were following up on our feedback from last week's Pharmacy meeting.
- Carried over notes from last week's pharmacy call
- In progress IG, for ballot in Jan: HL7.FHIR.UV.IPA\International Patient Access - FHIR v4.0.1
- PSS: [PSS-1808] International Patient Access - Jira (hl7.org)
- Med profiles:
FHIR (Group)
BR&R managed resources review
- no recent meetings
New Resource - FormularyItem
- January 21 - new resource proposal deadline for May 2022 ballot
Preparation for Normative
- Melva to work with John about QA needed
Trackers - link to pharmacy unresolved Jira trackers (see trackers for details / resolutions)
Any Other Business
Next meeting
- December 13, 2021